Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN095015-002
Application #
6353979
Study Section
Project Start
1999-03-15
Project End
2004-03-14
Budget Start
2000-09-29
Budget End
2001-03-14
Support Year
Fiscal Year
2000
Total Cost
$1,918,721
Indirect Cost
Name
Strang Cancer Prevention Center
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10021
Chan, Andrew T; Hsu, Meier; Zauber, Ann G et al. (2012) The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer Prev Res (Phila) 5:61-72
Chan, Andrew T; Sima, Camelia S; Zauber, Ann G et al. (2011) C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res (Phila) 4:1172-80
Chan, Andrew T; Zauber, Ann G; Hsu, Meier et al. (2009) Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 136:2127-2136.e1
Bertagnolli, Monica M; Eagle, Craig J; Zauber, Ann G et al. (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355:873-84
Carothers, Adelaide M; Moran, Amy E; Cho, Nancy L et al. (2006) Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor. Cancer Res 66:6432-8